These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Gold nanoparticles for the development of clinical diagnosis methods. Baptista P; Pereira E; Eaton P; Doria G; Miranda A; Gomes I; Quaresma P; Franco R Anal Bioanal Chem; 2008 Jun; 391(3):943-50. PubMed ID: 18157524 [TBL] [Abstract][Full Text] [Related]
6. Gold nanoparticle-based assays for the detection of biologically relevant molecules. White KA; Rosi NL Nanomedicine (Lond); 2008 Aug; 3(4):543-53. PubMed ID: 18694316 [TBL] [Abstract][Full Text] [Related]
7. Highly specific electrochemical analysis of cancer cells using multi-nanoparticle labeling. Wan Y; Zhou YG; Poudineh M; Safaei TS; Mohamadi RM; Sargent EH; Kelley SO Angew Chem Int Ed Engl; 2014 Nov; 53(48):13145-9. PubMed ID: 25283158 [TBL] [Abstract][Full Text] [Related]
8. Cancer detection using nanoparticle-based sensors. Perfézou M; Turner A; Merkoçi A Chem Soc Rev; 2012 Apr; 41(7):2606-22. PubMed ID: 21796315 [TBL] [Abstract][Full Text] [Related]
10. Gold nanoparticle-enabled blood test for early stage cancer detection and risk assessment. Zheng T; Pierre-Pierre N; Yan X; Huo Q; Almodovar AJ; Valerio F; Rivera-Ramirez I; Griffith E; Decker DD; Chen S; Zhu N ACS Appl Mater Interfaces; 2015 Apr; 7(12):6819-27. PubMed ID: 25757512 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in molecular recognition based on nanoengineered platforms. Mu B; Zhang J; McNicholas TP; Reuel NF; Kruss S; Strano MS Acc Chem Res; 2014 Apr; 47(4):979-88. PubMed ID: 24467652 [TBL] [Abstract][Full Text] [Related]
12. Detection of circulating cancer cells using electrocatalytic gold nanoparticles. Maltez-da Costa M; de la Escosura-Muñiz A; Nogués C; Barrios L; Ibáñez E; Merkoçi A Small; 2012 Dec; 8(23):3605-12. PubMed ID: 22893274 [TBL] [Abstract][Full Text] [Related]
13. Single gold nanoplasmonic sensor for clinical cancer diagnosis based on specific interaction between nucleic acids and protein. Ma X; Truong PL; Anh NH; Sim SJ Biosens Bioelectron; 2015 May; 67():59-65. PubMed ID: 24996253 [TBL] [Abstract][Full Text] [Related]
14. Fluorescence Sensing of Circulating Diagnostic Biomarkers Using Molecular Probes and Nanoparticles. Tagit O; Hildebrandt N ACS Sens; 2017 Jan; 2(1):31-45. PubMed ID: 28722447 [TBL] [Abstract][Full Text] [Related]
15. The emerging role of circulating tumor cell detection in genitourinary cancer. Small AC; Gong Y; Oh WK; Hall SJ; van Rijn CJ; Galsky MD J Urol; 2012 Jul; 188(1):21-6. PubMed ID: 22578722 [TBL] [Abstract][Full Text] [Related]
16. Gold nanoparticle amplified optical microfiber evanescent wave absorption biosensor for cancer biomarker detection in serum. Li K; Liu G; Wu Y; Hao P; Zhou W; Zhang Z Talanta; 2014 Mar; 120():419-24. PubMed ID: 24468391 [TBL] [Abstract][Full Text] [Related]
17. Marker expression in circulating cancer cells of pancreatic cancer patients. Zhou J; Hu L; Yu Z; Zheng J; Yang D; Bouvet M; Hoffman RM J Surg Res; 2011 Dec; 171(2):631-6. PubMed ID: 20869080 [TBL] [Abstract][Full Text] [Related]
18. Microfluidic bead-based multienzyme-nanoparticle amplification for detection of circulating tumor cells in the blood using quantum dots labels. Zhang H; Fu X; Hu J; Zhu Z Anal Chim Acta; 2013 May; 779():64-71. PubMed ID: 23663673 [TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Zen K; Zhang CY Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180 [TBL] [Abstract][Full Text] [Related]
20. Current research status of tumor cell biomarker detection. Jiang L; Lin X; Chen F; Qin X; Yan Y; Ren L; Yu H; Chang L; Wang Y Microsyst Nanoeng; 2023; 9():123. PubMed ID: 37811123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]